Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDEA594 and Allopurinol in Gout Patients
NCT01001338Phase 2Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Oct 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of lesinurad in gout, sponsored by Ardea Biosciences, Inc.. Started Oct 2009; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT01001338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001338.